Eli Lilly and Company
Condensed thiophene derivatives useful as NaPi-IIb inhibitors

Last updated:

Abstract:

The invention provides compounds of the formula: (A), pharmaceutically acceptable salts, pharmaceutical compositions thereof and methods of using these compounds, salts, or compositions to treat hyperphosphatemia, chronic kidney disease, and/or the cardiovascular disease associated with chronic kidney disease. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

8 Aug 2017

Issue date:

2 Mar 2021